{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:11:12Z","timestamp":1788991872129,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s10354-021-00818-w","type":"journal-article","created":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T09:04:54Z","timestamp":1613984694000},"page":"111-119","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Bone properties in osteogenesis imperfecta: what can we learn from a\u00a0bone biopsy beyond histology?","Knocheneigenschaften bei Osteogenesis imperfecta: Was k\u00f6nnen wir jenseits der Histologie aus einer Knochenbiopsie lernen?"],"prefix":"10.1007","volume":"171","author":[{"given":"Matthias","family":"M\u00e4hr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Blouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara M.","family":"Misof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios P.","family":"Paschalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus A.","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Zwerina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1164-1877","authenticated-orcid":false,"given":"Nadja","family":"Fratzl-Zelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,22]]},"reference":[{"issue":"6","key":"818_CR1","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/ajmg.a.36545","volume":"164A","author":"FS Van Dijk","year":"2014","unstructured":"Van Dijk\u00a0FS, Sillence\u00a0DO. Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am J Med Genet\u00a0A. 2014;164A(6):1470\u201381.","journal-title":"Am J Med Genet A"},{"issue":"13\u201314","key":"818_CR2","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s10354-015-0368-3","volume":"165","author":"N Fratzl-Zelman","year":"2015","unstructured":"Fratzl-Zelman\u00a0N, et al. Classification of osteogenesis imperfecta. Wien Med Wochenschr. 2015;165(13\u201314):264\u201370.","journal-title":"Wien Med Wochenschr"},{"issue":"9","key":"818_CR3","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrendo.2011.81","volume":"7","author":"A Forlino","year":"2011","unstructured":"Forlino\u00a0A, et\u00a0al. New perspectives on osteogenesis imperfecta. Nat Rev Endocrinol. 2011;7(9):540\u201357.","journal-title":"Nat Rev Endocrinol"},{"key":"818_CR4","doi-asserted-by":"publisher","first-page":"17052","DOI":"10.1038\/nrdp.2017.52","volume":"3","author":"JC Marini","year":"2017","unstructured":"Marini\u00a0JC, et\u00a0al. Osteogenesis imperfecta. Nat Rev Dis Primers. 2017;3:17052.","journal-title":"Nat Rev Dis Primers"},{"key":"818_CR5","doi-asserted-by":"publisher","first-page":"109789","DOI":"10.1016\/j.cellsig.2020.109789","volume":"76","author":"J Etich","year":"2020","unstructured":"Etich\u00a0J, et\u00a0al. Signaling pathways affected by mutations causing osteogenesis imperfecta. Cell Signal. 2020;76:109789.","journal-title":"Cell Signal"},{"issue":"13\u201314","key":"818_CR6","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s10354-015-0361-x","volume":"165","author":"H Hoyer-Kuhn","year":"2015","unstructured":"Hoyer-Kuhn\u00a0H, Netzer\u00a0C, Semler\u00a0O. Osteogenesis imperfecta: pathophysiology and treatment. Wien Med Wochenschr. 2015;165(13\u201314):278\u201384.","journal-title":"Wien Med Wochenschr"},{"issue":"1","key":"818_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40348-020-00101-9","volume":"7","author":"J Etich","year":"2020","unstructured":"Etich\u00a0J, et al. Osteogenesis imperfecta-pathophysiology and therapeutic options. Mol Cell Pediatr. 2020;7(1):9.","journal-title":"Mol Cell Pediatr"},{"issue":"3","key":"818_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00223-015-9978-4","volume":"97","author":"W Wagermaier","year":"2015","unstructured":"Wagermaier\u00a0W, Klaushofer\u00a0K, Fratzl\u00a0P. Fragility of bone material controlled by internal interfaces. Calcif Tissue Int. 2015;97(3):201\u201312.","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"818_CR9","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00467-006-0025-6","volume":"21","author":"F Rauch","year":"2006","unstructured":"Rauch\u00a0F. Watching bone cells at work: what we can see from bone biopsies. Pediatr Nephrol. 2006;21(4):457\u201362.","journal-title":"Pediatr Nephrol"},{"key":"818_CR10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s41970-020-00122-w","volume":"27","author":"BM Misof","year":"2020","unstructured":"Misof\u00a0BM, et al. Knochengewebe und -material in gesunden Menschen und bei Krankheit. J Miner Stoffwechs Muskuloskelet Erkrank. 2020;27:98\u2013101.","journal-title":"J. Miner. Stoffwechs. Muskuloskelet. Erkrank."},{"issue":"6","key":"818_CR11","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/jbmr.5650020617","volume":"2","author":"AM Parfitt","year":"1987","unstructured":"Parfitt\u00a0AM, et\u00a0al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR histomorphometry nomenclature committee. J\u00a0Bone Miner Res. 1987;2(6):595\u2013610.","journal-title":"J Bone Miner Res"},{"issue":"9418","key":"818_CR12","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","volume":"363","author":"F Rauch","year":"2004","unstructured":"Rauch\u00a0F, Glorieux\u00a0FH. Osteogenesis imperfecta. Lancet. 2004;363(9418):1377\u201385.","journal-title":"Lancet"},{"issue":"3","key":"818_CR13","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.bone.2007.10.021","volume":"42","author":"P Roschger","year":"2008","unstructured":"Roschger\u00a0P, et\u00a0al. Bone mineralization density distribution in health and disease. Bone. 2008;42(3):456\u201366.","journal-title":"Bone"},{"issue":"13\u201314","key":"818_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s10354-015-0369-2","volume":"165","author":"N Fratzl-Zelman","year":"2015","unstructured":"Fratzl-Zelman\u00a0N, et al. Bone mass and mineralization in osteogenesis imperfecta. Wien Med Wochenschr. 2015;165(13\u201314):271\u20137.","journal-title":"Wien Med Wochenschr"},{"issue":"6","key":"818_CR15","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.bone.2009.02.021","volume":"44","author":"N Fratzl-Zelman","year":"2009","unstructured":"Fratzl-Zelman\u00a0N, et al. Normative data on mineralization density distribution in iliac bone biopsies of children, adolescents and young adults. Bone. 2009;44(6):1043\u20138.","journal-title":"Bone"},{"issue":"3","key":"818_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s002239900600","volume":"64","author":"A Boyde","year":"1999","unstructured":"Boyde\u00a0A, et\u00a0al. The mineralization density of iliac crest bone from children with osteogenesis imperfecta. Calcif Tissue Int. 1999;64(3):185\u201390.","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"818_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00223-008-9113-x","volume":"82","author":"P Roschger","year":"2008","unstructured":"Roschger\u00a0P, et\u00a0al. Evidence that abnormal high bone mineralization in growing children with osteogenesis imperfecta is not associated with specific collagen mutations. Calcif Tissue Int. 2008;82(4):263\u201370.","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"818_CR18","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cell.2006.08.039","volume":"127","author":"R Morello","year":"2006","unstructured":"Morello\u00a0R, et al. CRTAP is required for prolyl 3\u2011hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell. 2006;127(2):291\u2013304.","journal-title":"Cell"},{"issue":"3","key":"818_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/ng1968","volume":"39","author":"WA Cabral","year":"2007","unstructured":"Cabral\u00a0WA, et al. Prolyl 3\u2011hydroxylase 1 deficiency causes a\u00a0recessive metabolic bone disorder resembling lethal\/severe osteogenesis imperfecta. Nat Genet. 2007;39(3):359\u201365.","journal-title":"Nat Genet"},{"issue":"4","key":"818_CR20","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/jbmr.2835","volume":"31","author":"N Bishop","year":"2016","unstructured":"Bishop\u00a0N. Bone material properties in osteogenesis imperfecta. J\u00a0Bone Miner Res. 2016;31(4):699\u2013708.","journal-title":"J Bone Miner Res"},{"issue":"6","key":"818_CR21","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1002\/jbmr.2173","volume":"29","author":"CR Farber","year":"2014","unstructured":"Farber\u00a0CR, et al. A novel IFITM5 mutation in severe atypical osteogenesis imperfecta type VI impairs osteoblast production of pigment epithelium-derived factor. J\u00a0Bone Miner Res. 2014;29(6):1402\u201311.","journal-title":"J Bone Miner Res"},{"issue":"8","key":"818_CR22","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1359\/jbmr.070418","volume":"22","author":"MS Cheung","year":"2007","unstructured":"Cheung\u00a0MS, Glorieux\u00a0FH, Rauch\u00a0F. Natural history of hyperplastic callus formation in osteogenesis imperfecta type V. J\u00a0Bone Miner Res. 2007;22(8):1181\u20136.","journal-title":"J Bone Miner Res"},{"issue":"9","key":"818_CR23","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1002\/jbmr.3180","volume":"32","author":"S Blouin","year":"2017","unstructured":"Blouin\u00a0S, et\u00a0al. Hypermineralization and high osteocyte lacunar density in osteogenesis Imperfecta type V bone indicate exuberant primary bone formation. J\u00a0Bone Miner Res. 2017;32(9):1884\u201392.","journal-title":"J Bone Miner Res"},{"key":"818_CR24","volume-title":"Bone tissue in murine atypical type VI osteogenesis imperfecta has changes in vascular pores and matrix organization, plus classic OI hypermineralization","author":"G Hedjazi","year":"2020","unstructured":"Hedjazi\u00a0G, et\u00a0al. Bone tissue in murine atypical type VI osteogenesis imperfecta has changes in vascular pores and matrix organization, plus classic OI hypermineralization. European Calcified Tissue Congress 2020; Marseille, France. 2020. digital conference."},{"issue":"3","key":"818_CR25","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s00223-015-9977-5","volume":"97","author":"M Granke","year":"2015","unstructured":"Granke\u00a0M, Does\u00a0MD, Nyman\u00a0JS. The role of water compartments in the material properties of cortical bone. Calcif Tissue Int. 2015;97(3):292\u2013307.","journal-title":"Calcif Tissue Int"},{"key":"818_CR26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.bone.2013.11.023","volume":"60","author":"N Fratzl-Zelman","year":"2014","unstructured":"Fratzl-Zelman\u00a0N, et al. Mineral particle size in children with osteogenesis imperfecta type I is not increased independently of specific collagen mutations. Bone. 2014;60:122\u20138.","journal-title":"Bone"},{"key":"818_CR27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.bone.2014.12.023","volume":"73","author":"N Fratzl-Zelman","year":"2015","unstructured":"Fratzl-Zelman\u00a0N, et al. Unique micro- and nano-scale mineralization pattern of human osteogenesis imperfecta type VI bone. Bone. 2015;73:233\u201341.","journal-title":"Bone"},{"issue":"8","key":"818_CR28","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1007\/s00198-017-4019-y","volume":"28","author":"EP Paschalis","year":"2017","unstructured":"Paschalis\u00a0EP, Gamsjaeger\u00a0S, Klaushofer\u00a0K. Vibrational spectroscopic techniques to assess bone quality. Osteoporos Int. 2017;28(8):2275\u201391.","journal-title":"Osteoporos Int"},{"issue":"5","key":"818_CR29","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/PL00005824","volume":"64","author":"S Rinnerthaler","year":"1999","unstructured":"Rinnerthaler\u00a0S, et al. Scanning small angle X\u2011ray scattering analysis of human bone sections. Calcif Tissue Int. 1999;64(5):422\u20139.","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"818_CR30","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.bone.2006.02.071","volume":"39","author":"M Weber","year":"2006","unstructured":"Weber\u00a0M, et\u00a0al. Pamidronate does not adversely affect bone intrinsic material properties in children with osteogenesis imperfecta. Bone. 2006;39(3):616\u201322.","journal-title":"Bone"},{"issue":"3","key":"818_CR31","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.bone.2009.10.037","volume":"46","author":"N Fratzl-Zelman","year":"2010","unstructured":"Fratzl-Zelman\u00a0N, et al. CRTAP deficiency leads to abnormally high bone matrix mineralization in a\u00a0murine model and in children with osteogenesis imperfecta type VII. Bone. 2010;46(3):820\u20136.","journal-title":"Bone"},{"issue":"9","key":"818_CR32","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1210\/jc.2016-1334","volume":"101","author":"N Fratzl-Zelman","year":"2016","unstructured":"Fratzl-Zelman\u00a0N, et al. Non-lethal type VIII osteogenesis Imperfecta has elevated bone matrix mineralization. J\u00a0Clin Endocrinol Metab. 2016;101(9):3516\u201325.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"818_CR33","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/jbmr.2780","volume":"31","author":"EP Paschalis","year":"2016","unstructured":"Paschalis\u00a0EP, et\u00a0al. Evidence for a\u00a0role for nanoporosity and pyridinoline content in human mild osteogenesis imperfecta. J\u00a0Bone Miner Res. 2016;31(5):1050\u20139.","journal-title":"J Bone Miner Res"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-021-00818-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10354-021-00818-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-021-00818-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T20:12:37Z","timestamp":1617307957000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10354-021-00818-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,22]]},"references-count":33,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["818"],"URL":"https:\/\/doi.org\/10.1007\/s10354-021-00818-w","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,22]]},"assertion":[{"value":"16 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.\u00a0M\u00e4hr, S.\u00a0Blouin, B.M.\u00a0Misof, E.P.\u00a0Paschalis, M.A.\u00a0Hartmann, J.\u00a0Zwerina and N.\u00a0Fratzl-Zelman declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}